Showing results (271-280 of 2,153) with videos related to
Sort By:
Pageof 216
Pharmacology & Toxicology|January 18, 2003
Amiodarone N-deethylation by CYP2C8 and its variants, CYP2C8*3 and CYP2C8 P404AAkiko Soyama, Nobumitsu Hanioka, Yoshiro Saito, et al.Pharmacology & Toxicology|July 25, 2000
The industry view on long-term toxicology testing in drug development of human pharmaceuticalsH Van Cauteren, P Bentley, G Bode, et al.Pharmacology & Toxicology|July 25, 2000
Spontaneous ADR reporting and drug safety signal induction in perspective. To honour Professor Jens SchouI R EdwardsPharmacology & Toxicology|July 25, 2000
Drug safety in relation to efficacy: the view of a clinical pharmacologistF SjöqvistPharmacology & Toxicology|July 15, 2000
Metabolism of desipramine in Japanese psychiatric patients: the impact of CYP2D6 genotype on the hydroxylation of desipramineK Shimoda, S Morita, G Hirokane, et al.Pharmacology & Toxicology|July 15, 2000
DNA adduct levels and intestinal lesions in congenic rapid and slow acetylator syrian hamsters admi food mutagens 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)I L Steffensen, A J Fretland, J E Paulsen, et al.Pharmacology & Toxicology|September 14, 2001
Aspects on the pathophysiology of migraine and cluster headacheL EdvinssonPharmacology & Toxicology|September 14, 2001
Ocular changes after intravitreal injection of methanol, formaldehyde, or formate in rabbitsY Hayasaka, S Hayasaka, Y NagakiPharmacology & Toxicology|September 14, 2001
Apoptotic effects of dichloro stearic and dichloro myristic acid in human hepatoma cells (HepG2)E Lystad, A T Høstmark, E JebensPharmacology & Toxicology|February 7, 2003
Adjuvant effect of di-n-butyl-, di-n-octyl-, di-iso-nonyl- and di-iso-decyl phthalate in a subcutaneous injection model using BALB/c miceSøren T Larsen, Rikke M Lund, Gunnar D Nielsen, et al.Pageof 216